 Connection
Spyridon Mastroyannis to Follow-Up Studies
This is a "connection" page, showing publications Spyridon Mastroyannis has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.115 |
|
|
|
-
Floyd J, Porragas-Paseiro H, Nguyen C, Moroney MR, Mastroyannis S, Guntupalli SR. Validation of the Safety and Efficacy of Apixaban as Postoperative Thromboembolism Prophylaxis for Patients with Gynecologic Malignancies. Ann Surg Oncol. 2024 Aug; 31(8):5102-5110.
Score: 0.029
-
Nasioudis D, Mastroyannis SA, Latif NA, Ko EM, Haggerty AF, Kim SH, Morgan MA, Giuntoli RL. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database. Surg Oncol. 2021 Sep; 38:101589.
Score: 0.024
-
Nasioudis D, Mastroyannis SA, Haggerty AF, Giuntoli RL, Morgan MA, Ko EM, Latif NA. Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary. Eur J Obstet Gynecol Reprod Biol. 2020 May; 248:63-70.
Score: 0.022
-
Nasioudis D, Wilson E, Mastroyannis SA, Sisti G, Haggerty AF, Ko EM, Latif NA. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors. Anticancer Res. 2019 Sep; 39(9):4971-4975.
Score: 0.021
-
Hannah-Shmouni F, Moraitis AG, Romero VV, Faucz FR, Mastroyannis SA, Berthon A, Failor RA, Merino M, Demidowich AP, Stratakis CA. Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate. Horm Metab Res. 2018 02; 50(2):124-132.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|